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Abstract
Cancer is a disease that stems from genomic errors that are not corrected properly by cellular
repair mechanisms. Errors are more likely to form when organisms are subjected to DNA
damage by mutagenic compounds. 1-Nitropyrene, a nitrated polycyclic aromatic hydrocarbon
(nitro-PAH), has been shown to be a potent mutagen that causes cancer. Nitro-PAHs can arise
from diesel exhaust products in the environment. Out of all nitro-PAHs, 1-nitropyrene is found in
largest quantities in the environment. This poses a great need to study its effects biochemically in
order to address its toxicity in DNA. Other nitropyrene derivatives, including 1,6-dinitropyrene
and 1,8-dinitropyrene, are known to be much more carcinogenic than 1-nitropyrene itself. 1Nitropyrene reacts with DNA and forms two 2’-deoxyguanosine (dG)-N2 adducts: dG-N2-6aminopyrene and dG-N2-8-aminopyrene. These adducts retain the same conformations as 1,6dinitropyrene and 1,8-dinitropyrene, respectively. This study assesses each adduct’s toxicity in
AB1157 Escherichia coli cells. It was found that dG-N2-6-aminopyrene and dG-N2-8aminopyrene both have negative effects on bacterial cell viability. However, dG-N2-6aminopyrene was found to be more toxic than dG-N2-8-aminopyrene.
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1. Introduction
1.1 Carcinogenesis
Cancer is a devastating disease and is a major public health concern worldwide. In fact, it is
currently the second leading cause of death in the United States.1 Cancer onset is initiated by
genetics or external stressors found within the environment.2 These two components are
intricately analyzed in oncology in order to determine how carcinogenesis starts molecularly.
It has been found that the environment plays a significant role in carcinogenesis.
Exposure to both man-made and natural substances in the environment accounts for at least twothirds of cancer cases in the United States.3 Carcinogens can arise from cigarette smoke, the
consumption of alcohol or even too much sun exposure.4 These substances ultimately lead to the
development of acquired errors in DNA. These errors are also known as mutations. Acquired
mutations can detrimentally affect the cell cycle of somatic cells if protein synthesis is negatively
impacted, which may lead to the formation of cancer.5

1.2 DNA and Repair Mechanisms
The basis of all life starts with DNA and its particular sequence of nitrogenous bases. DNA
determines vital information needed to build and maintain an organism. Our cells require this
information in order to proliferate and carry out specific functions.6 Sometimes DNA can be
altered within the cell. Humans have between 20,000 and 25,000 genes.7 With so much DNA, it
is possible for replication proteins to make mistakes in DNA synthesis. One example of a
mistake is when a base in an original DNA sequence is replaced with an incorrect base. Every
time cell division occurs with changed sequences, mutations can build up. If the information is
altered constantly and mutations accumulate without repair, these mutations can negatively
impact normal cellular functions.8
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It should be noted that mutations happen in our cells constantly.8 Cells have enzymes and
genes that can detect these DNA errors and repair them. For example, enzymes called
polymerases participate in repair mechanisms that identify mismatched bases and correct them.
Their functions are of great interest in oncologic research and are commonly studied in various
types of cells. If repair mechanisms by polymerases are not successful, cells will undergo cycle
failure.9
Environmental Stressors
. Chemicals
. UV Radiation
. Microorganisms

Inherited Mutations

DNA polymerases
can participate in…
. Mismatch Repair
. Base Excision Repair
. Nucleotide Excision Repair
. Homologous Recombination
. End Joining
Successful Repair
Normal Cell Cycle
Processes

Failure
. Cell Cycle Arrest (G0)
. Apoptosis
. Mutation Propagation

Figure 1. Agents of DNA damage, polymerase repair mechanisms and possible outcomes.9

1.3 Nitrated Polycyclic Aromatic Hydrocarbons (Nitro-PAHs)
One class of chemical carcinogens that is commonly found in the environment is the nitro-PAHs.
These compounds are derivatives of PAHs with at least one nitro-functional group on one of two or
more fused aromatic rings.10,12 They are either formed from their parent PAHs by atmospheric
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reactions or are directly emitted from diesel and gasoline engines.11 When nitro-PAHs are
emitted into the air, they can enter the body through the lungs or skin. They tend to be stored in
fatty tissues but usually exit the body within a few days.13

Figure 2. A selection of nitro-PAHs with their parent PAHs: phenanthrene [11], 9-nitrophenanthrene [12], fluoranthene [13], 2-nitrofluoranthene [14], 3,9-dinitrofluoranthene
[15], pyrene [16], 1-nitropyrene [17], 1,3-dinitropyrene [18], 1,6-dinitropyrene [19], 1,8dinitropyrene [20], chrysene [21], 6-nitrochrysene [22], benzo[a]pyrene [23], 6nitrobenzo[a]pyrene [24], 3,6-dinitrobenzo[a]pyrene [25].10

Nitro-PAHs are widely studied because they are known to exhibit more toxic
characteristics than their parent PAHs.11 In fact, their toxic properties have been analyzed and
assigned toxicity equivalency factors (TEFs) much larger than their related PAHs. They have
been proven to induce DNA damage, the formation of DNA adducts, changes in gene and
protein expression, cell cycle alternations and more.10 Some of the most abundant nitro-PAHs
found in diesel particulate matter include 1-nitropyrene, 3-nitrobenzo[e]pyrene, 7nitrobenz[a]anthracene, 3-nitrofluoranthene, 9-nitroanthracene and three dinitropyrene isomers
(1,3-dinitropyrene, 1,6-dinitropyrene and 1,8-dinitropyrene).14

8

1.4 Nitropyrene Compounds
Nitropyrene compounds are considered types of nitro-PAHs. Many nitropyrene derivatives are
frequently studied because of their carcinogenic effects. The major derivatives of nitropyrene
found in the environment include 1-nitropyrene, 2-nitropyrene, 4-nitropyrene, 1,3-dinitropyrene,
1,6-dinitropyrene and 1,8-dinitropyrene (Figure 3).15

Figure 3. Major nitropyrene derivatives.

1-Nitropyrene is found in alarmingly higher concentrations in diesel particulate matter
compared to the other abundant nitro-PAHs (16.4 +/- .1 µg/g vs. the next highest compound 3nitrobenzo[e]pyrene 2.2 +/- .2 µg/g).14 1-Nitropyrene specifically has also been detected in urban
air particulates, certain grilled foods, and emissions from wood stoves, fire places, gas burners
and kerosene heaters. Its toxicity is evident in its ability to act as a potent mutagen in both
mammalian and bacterial systems.16
The fact that 1-nitropyrene is so toxic is attractive to scientists to study its role in cancer
onset. On the other hand, there is evidence that other nitropyrenes may have more harmful
effects on human health. 1,6-Dinitropyrene has been shown to be more mutagenic and
carcinogenic than 1-nitropyrene even though it is present in smaller quantities in diesel exhaust.17
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In a past study that tested the tumorigenic abilities of both 1-nitropyrene and 1,6-dinitropyrene,
1,6-dinitropyrene was shown to be much more tumorigenic in equimolar doses. The compound
induced malignant fibrous histiocytomas, leukemias and mammary gland tumors.17 Additionally,
1,8-dinitropyrene was shown to be mutagenic for mouse lymphoma L5178Y cells because it
induced resistance to certain cancer drugs.18

1.5 DNA Adducts
As mentioned previously, carcinogenesis depends on the development of DNA mutations. The
reason why nitropyrenes are so mutagenic manifests in their ability to form adducts within DNA.
Via xanthine oxidase-catalyzed nitroreduction of 1-nitropyrene, one adduct previously identified
as N-(deoxyguanosin-8-yl)-1-aminopyrene (C8-dG-AP) was shown to form in both mammalian
and bacterial cells.16 Scientists later discovered that there are two additional DNA adducts that
form via enzymatic and chemical nitroreduction of 1-nitropyrene with calf thymus DNA. The
two found were deoxyguanosine (dG) -N2 adducts (dG-N2-6-aminopyrene and dG-N2-8aminopyrene or dG-N2-6-AP and dG-N2-8-AP, respectively).16

Figure 4. Basic schema of 1-nitropyrene nitroreduction. N-Hydroxy-1-aminopyrene and 1aminopyrene can be modified further to form compounds that react directly with DNA bases.15,19
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dG-N2-6-AP and dG-N2-8-AP have different conformations that are derived from 1,6dinitropyrene and 1,8-dinitropyrene, respectively. Their reaction with guanine is influenced by
the regioselectivity of guanine with respect to the substituted amino group.20 These variations
may influence the level of toxicity prevalent in each adduct.

C8-dG-AP

dG-N2-8-AP

dG-N2-6-AP

Figure 5. Structures of discovered 1-nitropyrene adducts.15

2. Materials
All reagents, solvents, equipment and enzymes used were purchased from Thermo Fisher
Scientific (Agawam, MA), Sigma-Aldrich (St. Louis, MO) and NEB (Ipswich, MA).
Unmodified oligonucleotides were ordered from Integrated DNA Technologies (Coralville, IA).
The 12-mer oligonucleotides containing the dG-N2-AP adducts were synthesized by C. Malik
(University of Connecticut, Storrs CT). They reacted at G* of sequence 5’-GTGCG*TGTTTGT3’. The oligomers were purified using 20% denaturing polyacrylamide gel electrophoresis
(PAGE) by C. Surugihalli. The plasmid used for study (pMS2) was gifted by M. Moriya (SUNY,
Stony Brook NY). Finally, [γ-32P] ATP was ordered from Perkin Elmer (Waltham, MA).
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3. Methods
3.1 Purity Check of Oligonucleotides
Oligonucleotides with site-specific lesions (1,6 dG and 1,8 dG) at G* of p53 gene sequence 5’GTGCG*TGTTTGT-3’, as well as an unmodified control, were checked for purity. Purity was
assessed by PAGE using [γ-32P] ATP. The oligomers were run in excess, were labeled at 5’ and
ran on the gel with dye at 2500 V for 6 hours at room temperature. The image was seen through
autoradiography. Oligomer concentrations were confirmed by NanoDrop.

3.2 pMS2 Preparation
pMS2 is a plasmid with 5137 DNA base pairs. It has both bacterial (fl) and mammalian (SV40)
origins of replication. It also has antibiotic resistance genes for ampicillin (AmpR) and neomycin
(NeoR) (Figure 6).15 The multiple cloning site (MCS) has a hairpin loop with a restriction site for
restriction endonuclease EcoRV. EcoRV cleaves at * of the sequence 5’…GAT*ATC…3’ and
creates blunt ends (Figure 7).21

Figure 6. pMS2 with origins of replication, antibiotic resistance genes and a multiple cloning
site specific for EcoRV.
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Figure 7. Hairpin loop within the MCS of pMS2, which contains a restriction site for EcoRV.
Fifty ng of pMS2 (double stranded replicative form) was carefully mixed with 50 μL of
electro-competent E. coli DH12S cells. The mixture was transferred to an ice-cold 1-mm gapped
electroporation cuvette. Electroporation was done at 1.8 kV with a resistance of 200 Ω and 25 μF
charge, which was quickly followed by the addition of 1 mL pre-warmed (37°C) SOC media.
Contents were transferred to a 14 mL Falcon® tube and were incubated at 37°C in a shaker at
230 rpm for 1 hour. The bacterial culture was then made into 2 dilutions (1:100 and 1:50) using
200 μL of 1X YT media for each. Each dilution was spread onto pre-warmed (37°C) 1X YT with
ampicillin (100 μg/mL) plates, and cultures were grown overnight in a sterile incubator at 37°C.
Approximately 100 colonies were scraped from each plate the next day using a sterile
loop. Each dilution was individually scraped and inoculated into separate sterile 2 L flasks
containing 400 mL of 2X YT liquid media aseptically. 1 mL of M13K07 helper phage was also
pipetted into each flask. Each mixture was incubated at 37°C in a shaker at 250 rpm for 2 hours.
After this incubation, 100 μg/mL of kanamycin was added to each flask. Each mixture incubated
overnight in a shaker at the same conditions.
The cultures were transferred into sterile 250 mL centrifuge bottles and were spun at
10000 rpm for 15 minutes at 4°C. Supernatant was taken and transferred into another set of
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sterile 250 mL bottles and spun again at the same conditions. The supernatant was then
transferred to an ice-cold, sterile 2 L flask containing 4% (w/v) polyethylene glycol (PEG 8000)
and 2.5 M NaCl. The mixture was stirred in an ice-bath for 2 hours, and the resulting solution
was transferred into another sterile set of 250 mL centrifuge bottles. Centrifugation occurred at
10000 rpm for 30 minutes at 4°C in order to precipitate out the DNA. Supernatant was discarded,
and the pellets were re-suspended in 6 mL of 1X Tris-EDTA (pH 7.6) buffer. The resulting
mixtures were aliquoted into 2 mL centrifuge tubes and were centrifuged at 10000 rpm for 10
minutes at room temperature in order to remove insoluble PEG. The supernatant was then
collected and transferred into a 14 mL Falcon® tube. To remove possible protein impurities, the
supernatant was mixed with 200 μL of 10X TE (pH 8), 500 μL of 10% SDS, 156 μL of 20
mg/mL Proteinase K and 144 μL of sterile deionized water. These added volumes are dependent
on the supernatant volume, which was 4 mL. The tube was incubated at 42°C for 16 hours.
The last day of preparation consisted of additional purification steps at room temperature.
Extractions were carried out with phenol-chloroform-ISA (1:1) until the solution became clear.
Each extraction required a 20-minute centrifugation at 14000 rpm. An additional extraction was
done with chloroform-ISA (24:1) once. Centrifugation was for 10 minutes at 14000 rpm.
Purification was completed with Amicon®-100 K columns. Columns were first filled with pMS2
mixture and centrifuged at 14000 rpm for 2 minutes. 2 sterile deionized water washes followed.
350 μL of water was added to each column prior to each wash, and centrifugation occurred under
the same conditions. The contents in the columns were collected in 1 vial by centrifuging at
14000 rpm for 1 minute. The plasmid was confirmed by 1.1% agarose gel, and its concentration
was quantified using UV. Various volumes of plasmid were run to see which volume was best
for visualization.
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3.2 pMS2 Construct Preparation
Preparation is briefly summarized by Figure 8. 5 μg of single-stranded pMS2 (sspMS2) was first
incubated with 2.5 μL of 10X CutSmart® Buffer at 37°C for 1 hour. The solution was
centrifuged at room temperature at 14000 rpm for 10 minutes. The supernatant was next digested
with restriction endonuclease EcoRV. This was done by adding 18.8 μL of sterile deionized
water and 1.7 μL of the enzyme together. This entire procedure was done twice more in order to
fill 3 mini centrifuge tubes (total volume = 25 μL in each). The reaction occurred in a 37°C water
bath for 14 hours. The cuts were confirmed by agarose gel electrophoresis. 2 μL of each reaction
mixture and 2 μL of uncut pMS2 (control) were used to run on a 1.1% agarose gel.
In order for the aminopyrene adducts to be properly inserted inside the pMS2, a scaffold
is required to facilitate insertion. A 58-mer oligonucleotide scaffold, which is complementary to
each 12-mer lesioned sequence, was annealed to the linear pMS2. This was done by combining
each cut plasmid with 1 μL of complimentary scaffold, 2.3 μL of 1 M NaCl, and 1 μL of sterile
deionized water. The mixtures were heated to 80°C and then were cooled gradually to room
temperature overnight. The next day, the plasmids were kept at 4°C for at least 12 hours. The
scaffolded products were run on another 1.1% agarose gel along with cut pMS2 (control) for
quantification. This was done by comparing net intensities with the control under UV light.
Unmodified and aminopyrene modified 12-mer inserts were then phosphorylated at the 5’
end. This was done by mixing each insert separately with 2.5 μL of 10X Ligase buffer, 2.5 μL of
T4 Polynucleotide Kinase and varying volumes of sterile deionized water that depended on the
volume of the insert (total volume = 25 μL). Phosphorylation occurred at 37°C for 1 hour. Inserts
were later ligated to the scaffolded pMS2. Each insert was combined with scaffolded plasmid,
7.6 μL of 10X Ligase buffer, 11.4 μL of sterile deionized water and 5 μL of T4 DNA Ligase.
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Ligation occurred at 16°C for 18 hours. Excess ligase (1 μL) was added to each after the 18
hours to ensure complete ligation, and the constructs were prepared for de-scaffolding after
another 8 hours at 16°C.
The annealed scaffold was removed by adding 15.2 μL of 10X NEBuffer, 52.8 μL of
sterile deionized water, 5 μL of Uracil DNA Glycosylase and 1 μL of Exonuclease-III to each
mixture. De-scaffolding occurred at 16°C for 17 hours. The constructs were extracted by passing
each mixture through 100 KDa centrifuge columns (Amicon®-100 K columns). This procedure
is the same as the one depicted in plasmid preparation. The final sspMS2 constructs were again
quantified using a 1.1% agarose gel.
EcoRVdigestion &
scaffolding

Ligate oligo &
remove scaffold

Replicate in E.
coli and
analyze
progeny

Figure 8. Diagram of pMS2 construct preparation. X represents the added aminopyrene inserts.
This was also followed for preparing the unmodified control construct.

3.3 Preparation of Electro-competent AB1157 E. coli Cells
In order to assess the toxicity of the dG-N2 adducts, electro-competent E. coli cells were prepared
and used as bacterial expression systems. It is said that life evolved from single-celled
organisms. They possess simple biochemical processes that are very similar to processes in
eukaryotic cells. Thus, studying the effects of the adducts in E. coli can provide beneficial data
for future studies with mammalian cells.
An AB1157 E. coli cell stock was made electro-competent in a 3-day procedure. First,
cells from the stock were streaked on a 1X LB plate in order to isolate single colonies. The plate
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was incubated in a sterile incubator at 37°C overnight. On the second day, 10 mL of sterilized
1X LB liquid media was poured into a 50 mL Falcon® tube using aseptic technique. 1 isolated
single colony was inoculated into the media and was incubated in a shaker at 37°C for 16 hours
at 230 rpm.
After 16 hours, 4 mL of the overnight culture was transferred aseptically into a 2 L flask
containing 200 mL of 1X LB. The culture was allowed to grow for 2 additional hours at 37°C
and 230 rpm. The flask was then moved to an ice-bath for 15 minutes, and the media was
transferred into ice-cold 250 mL centrifuge bottles. Centrifugation occurred at 0°C for 17
minutes at 5000 rpm. The supernatant was decanted, and 10 mL of sterile deionized water was
added to each pellet for washing. The pellets were re-suspended and again centrifuged at the
same conditions. Supernatant was decanted again, and a second washing occurred under the
same conditions except 5 mL of sterile deionized water was added to each pellet. Lastly, 200 μL
of 10% glycerol was added to 1 pellet, re-suspended, and was distributed among the other
pellets. After each pellet was re-suspended, cells were aliquoted into multiple ice-cold microfuge
tubes. The tubes that were not used for toxicity analysis were stored at -80°C for future use.

3.4 Toxicity Analysis
75 ng of both modified (1,6 dG and 1,8 dG aminopyrene) and unmodified lesions were
individually electroporated into 50 μL of ice-cold electro-competent AB1157 E. coli cells. The
same conditions for electroporation for pMS2 preparation were followed. After incubation,
colonies of each type of lesion were counted. To measure the toxicity of each adduct, modified
lesions were compared to unmodified controls. This data was expressed as a percentage:
# 𝑜𝑓 𝑑𝐺 𝐴𝑃 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠
x 100
# 𝑜𝑓 𝐶𝑇 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠

4. Results
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4.1 PAGE Purification Assessment
12-mer oligonucleotides were checked for purity and selected for further experimentation based
on results. Any bands below the weight of the oligonucleotides (bold bands) were considered
impurities, and oligonucleotides that presented with these bands were not used. A slight increase
in weight presented by the modified oligomers compared to unmodified controls was noted. This
is due to the bulkiness of the aminopyrene adducts.

x

x

CT 1,6 1,8 1,8 1,8 CT 1,8

Figure 9. Polyacrylamide gel image of [γ-32P] ATP-labeled oligonucleotides. Lanes with X’s were
not used for further study.

4.2 Preparation of sspMS2
After preparation, the plasmid was confirmed by 1.1% agarose gel, and the concentration was
quantified to proceed with construct preparation. Figure 10 shows the image of the gel. The
circular sspMS2 obtained is represented as a single band in the box by UV light.
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1

2

3

4

Figure 10. Agarose gel image (1.1%) of collected pMS2 with controls. Lane 1: Freshly obtained
circular sspMS2, Lanes 2*, 3+4: Old control sspMS2.
*

= Lane 2 had un-pure plasmid, which was apparent by the bright bands above the plasmid band.

4.3 Preparation of Construct
Gel images were taken after each main step of preparation. The EcoRV cut was confirmed by
Figure 11, and the images of modified and unmodified lesions after de-scaffolding proved that
the overall preparation was successful (Figures 12 and 13).

1

2

3

4

Figure 11. Agarose gel image (1.1%) of restriction enzyme EcoRV cut. Lane 1: Circular pMS2
(control), Lanes 2, 3+4: Linear sspMS2.
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1

2

3
Figure 12. Agarose gel image (1.1%) of final de-scaffolded
products. Lane 1: pMS2 (control), Lane 2: Unmodified
construct, Lane 3: Modified construct containing dG-N2-6AP.

Figure 13. Agarose gel image (1.1%) of final de-scaffolded

1

2

3

products. Lane 1: pMS2 (control), Lane 2: Unmodified
construct, Lane 3: Modified construct containing dG-N2-8AP.

4.4 Toxicity Results
75 ng of adducted and control constructs were electroporated with prepared AB1157 E. coli
cells. The difference in cell count between lesion-containing and control colonies represents
adduct toxicity, which is also expressed as a percentage. The lower the percentage, the more
toxic the lesion can be considered.
It should be noted that the experiment with dG-N2-6-AP produced much more colonies
than with dG-N2-8-AP. This may be because dG-N2-6-AP was done right after AB1157 cell
preparation, whereas dG-N2-8-AP was done 3 weeks later. The time difference did not negatively
impact transfection efficiencies, for time constants did not differ significantly (4.5-5.0).
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# of Counted
Colonies

Adduct

Total Colony Count

Trial 1

Trial 2

CT

9558

8645

18203

dG-N2-6-AP

3943

3121

7064

Toxicity %

39%

Table 1: Toxicity results of AB1157 E. coli cells with dG-N2-6-AP.

# of Counted
Colonies

Adduct

Total Colony Count

Trial 1

Trial 2

CT

2506

2417

4923

dG-N2-8-AP

1612

1357

2969

60%

Table 2: Toxicity results of AB1157 E. coli cells with dG-N2-8-AP.

80

Toxicity Percentage

70
60
50
40

30
20
10
0
dG-N2-6-AP

Toxicity %

dG-N2-8-AP

Modified Adduct

Figure 14: Graph of Toxicity Percentages Among Modified Adducts.
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5. Conclusion and Discussion
The objective of this project was to address the toxicities of two adducts formed by 1nitropyrene: dG-N2-6-AP and dG-N2-8-AP. These adducts were shown to be detrimental to the
survivability of AB1157 E. coli cells after transfection by electroporation when compared to
unmodified control cells. The calculated toxicity percentage of dG-N2-6-AP was much less than
the percentage of dG-N2-8-AP (39% vs. 60%), which demonstrates that dG-N2-6-AP has a higher
toxic effect on the viability of bacterial cells.
This study is just a snippet of what can be researched further. It is possible to analyze
what happens to bacterial DNA biochemically and discover what causes modified cells to
undergo apoptosis. Thus, cells can be sequenced in order to discover any modifications that may
have occurred in the p53 sequence. Modifications will indicate the presence of mutations that
formed by the adducts. Future studies are also required to elucidate DNA repair mechanisms and
to discover why mutations may exist. This research may be applied to mammalian systems in
order to provide more data that can be beneficial for the future of human health and the
environment.
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